Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | CA3 | P07451 | 3/20 | 0.54 |
| ▸ | CA4 | P22748 | 3/20 | 0.54 |
| ▸ | CA6 | P23280 | 3/20 | 0.54 |
| ▸ | CA5A | P35218 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1397053 | 1.00 | APP (0.59) | APPKDM4EALDH1A1LMNATP53 | |
| SCHEMBL891764 | 1.00 | APP (0.59) | APPKDM4EALDH1A1LMNATP53 | |
| Hydrochloric Acid SCHEMBL10484291 | 0.97 | APP (0.56) | APPKDM4EALDH1A1LMNATP53 | |
| SCHEMBL18199531 | 0.93 | PTGES (0.53) | APPKDM4EALDH1A1LMNATP53 | |
| Phenol SCHEMBL3488360 | 0.91 | APP (0.50) | APPKDM4EALDH1A1LMNATP53 | |
| 4-Vinylphenol SCHEMBL17478290 | 0.89 | APP (0.48) | APPKDM4EALDH1A1LMNATP53 | |
| SCHEMBL2045167 | 0.87 | APP (0.46) | APPKDM4EALDH1A1LMNATP53 | |
| SCHEMBL2045166 | 0.87 | APP (0.46) | APPKDM4EALDH1A1LMNATP53 | |
| SCHEMBL10270315 | 0.87 | MEN1 (0.50) | APPKDM4EALDH1A1LMNATP53 | |
| SCHEMBL9461723 | 0.85 | CYP3A4 (0.65) | APPKDM4EALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| CN-117462421-A | Double-layer lipid microsphere emulsion with targeting function and preparation method thereof | 贵州九立德生物制药有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116589515-A | Preparation method of p-propenyl phenol glycoside with whitening effect | 云南中医药大学 | 2023-08-15 | — | — | CN | claimed |
| CN-114452291-B | Application of clavulanoside A in preparation of medicines for inhibiting hepatic fibrosis | 玉林市中医医院 | 2023-08-04 | — | — | CN | claimed |
| CN-116393150-A | Preparation method of potassium fluoride modified hydrotalcite solid base catalyst | 江苏飞亚化学工业集团股份有限公司 | 2023-07-07 | — | — | CN | claimed |
| WO-2023067228-A1 | SYNTHESIS OF A SYN-CIS AND TRANS 2,4,7,9-TETRAMETHYLDECYNE-4,7-DIOL MIXTURE BY CATALYTIC PARTIAL HYDROGENATION WITH MOLECULAR HYDROGEN | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2023-04-27 | — | — | WO | claimed |
| EP-4142681-A1 | ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS, MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDS | L'OREAL (FR) | 2023-03-08 | — | — | EP | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-114452291-A | Application of robustoside A in preparation of medicine for inhibiting hepatic fibrosis | 玉林市中医医院 | 2022-05-10 | — | — | CN | claimed |
| US-8163806-B2 | Controlled release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2012-04-24 | — | — | US | claimed |
| US-20120010284-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2012-01-12 | — | — | US | claimed |
| US-6153226-A | VIRICIDAL COMPOSITION COMPRISING A SYNERGISTIC MIXTURE OF A PHENOL COMPONENT AND PROPOLIS; THE PHENOL IS A MONO- OR POLYHYDROXYLATED COMPOUND COMPRISING A NONFUSED OR FUSED BENZENE RING | FILECO (FR) | 2000-11-28 | — | — | US | claimed |
| CN-1206434-A | Perfumes for laundry and cleaning compositions | PROCTER & WILLIAM (US) | 1999-01-27 | — | — | CN | claimed |
| EP-0521906-A1 | THERAPEUTIC COMPOSITION CONTAINING A PHENOL COMPOUND AND PROPOLIS USEFUL AGAINST LIPIDIC CAPSIDE VIRUSES, ESPECIALLY THE HERPES VIRUSES | FILECO (FR) | 1993-01-13 | — | — | EP | claimed |
| WO-1991013626-A1 | THERAPEUTIC COMPOSITION CONTAINING A PHENOL COMPOUND AND PROPOLIS USEFUL AGAINST LIPIDIC CAPSIDE VIRUSES, ESPECIALLY THE HERPES VIRUSES | FILECO (FR) | 1991-09-19 | — | — | WO | claimed |
| US-4963463-A | Radiation-sensitive resin composition with admixtures of O-quinone diazide and acid esters having nitrobenzyl or cyanobenzyl group | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-10-16 | — | — | US | claimed |
| EP-0330406-A2 | Radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1989-08-30 | — | — | EP | claimed |
| US-4468508-A | Glycidyl ether of novolak type substituted phenolic resin, process for producing the same, and encapsulating compound composed mainly of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| US-20260085281-A1 | Production of Culture Medium through Microbial Co-Hydrolysis of Plant Proteins | BTL HEALTHCARE TECHNOLOGIES AS (CZ) | 2026-03-26 | — | — | US | disclosed |
| US-4102859-A | PHOSPHOROUS ACID ESTERS WITH OXETANE COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010284-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, AADAC, LGMN | APP 301/4885KDM4E 4077/4885ALDH1A1 1550/4885 |
| US-20260085281-A1 | Production of Culture Medium through Microbial Co-Hydrolysis of Plant Proteins | NOTUM, CTRL, PEPD | APP 362/4885KDM4E 2622/4885ALDH1A1 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.